Parkinsonism secondary to duloxetine use: a case report.

about

Parkinsonism secondary to duloxetine use: a case report.

Item

http://www.wikidata.org/entity/Q55112412

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Parkinsonism secondary to duloxetine use: a case report.

@en

Parkinsonism secondary to duloxetine use: a case report.

@nl

type

Item

label

Parkinsonism secondary to duloxetine use: a case report.

@en

Parkinsonism secondary to duloxetine use: a case report.

@nl

prefLabel

Parkinsonism secondary to duloxetine use: a case report.

@en

Parkinsonism secondary to duloxetine use: a case report.

@nl

P1476

Parkinsonism secondary to duloxetine use: a case report.

@en

P2093

Arzu Bayrak

http://www.w3.org/2001/XMLSchema#string

Bugra Cetin

http://www.w3.org/2001/XMLSchema#string

Handan Meteris

http://www.w3.org/2001/XMLSchema#string

Sermin Kesebir

http://www.w3.org/2001/XMLSchema#string

P2860

"Dopamine-dependent" side effects of selective serotonin reuptake inhibitors: a clinical review

Extrapyramidal symptoms associated with antidepressants--a review of the literature and an analysis of spontaneous reports

Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents

SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment.

Metabolism of atypical antipsychotics: involvement of cytochrome p450 enzymes and relevance for drug-drug interactions.

A Case of SSRI Induced Irreversible Parkinsonism.

Duloxetine: clinical pharmacokinetics and drug interactions.

Extrapyramidal symptoms associated with cyclic antidepressant treatment: a review of the literature and consolidating hypotheses.

Selective serotonin-reuptake inhibitor-induced movement disorders.

Parkinsonism associated with a serotonin and noradrenaline reuptake inhibitor, milnacipran.

P304

243-246

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.14744/NCI.2015.63634

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28058376

http://www.w3.org/2001/XMLSchema#string

P932

5175115

http://www.w3.org/2001/XMLSchema#string